{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:59:23Z","timestamp":1790315963011,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009091","name":"FCT","doi-asserted-by":"publisher","award":["NORTE 2020"],"award-info":[{"award-number":["NORTE 2020"]}],"id":[{"id":"10.13039\/501100009091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009091","name":"FCT","doi-asserted-by":"publisher","award":["SFRH\/BD\/112201\/2015"],"award-info":[{"award-number":["SFRH\/BD\/112201\/2015"]}],"id":[{"id":"10.13039\/501100009091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009091","name":"FCT","doi-asserted-by":"publisher","award":["PD\/BD\/105976\/2014"],"award-info":[{"award-number":["PD\/BD\/105976\/2014"]}],"id":[{"id":"10.13039\/501100009091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009091","name":"FCT","doi-asserted-by":"publisher","award":["SFRH\/BD\/113031\/2015"],"award-info":[{"award-number":["SFRH\/BD\/113031\/2015"]}],"id":[{"id":"10.13039\/501100009091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009091","name":"FCT","doi-asserted-by":"publisher","award":["SFRH\/BD\/99036\/2013"],"award-info":[{"award-number":["SFRH\/BD\/99036\/2013"]}],"id":[{"id":"10.13039\/501100009091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.actbio.2018.09.043","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T03:54:12Z","timestamp":1538020452000},"page":"208-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6"],"prefix":"10.1016","volume":"81","author":[{"given":"Patrick J.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Nestor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro L.","family":"Granja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-7553","authenticated-orcid":false,"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2018.09.043_b0005","doi-asserted-by":"crossref","first-page":"12160","DOI":"10.1073\/pnas.89.24.12160","article-title":"Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons","volume":"89","author":"Screaton","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.actbio.2018.09.043_b0010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc3023","article-title":"CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?","volume":"11","author":"Z\u00f6ller","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2018.09.043_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0092-8674(91)90403-L","article-title":"A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells","volume":"65","author":"G\u00fcnthert","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2018.09.043_b0020","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1101\/gad.242602","article-title":"CD44 is required for two consecutive steps in HGF\/c-Met signaling","volume":"16","author":"Orian-Rousseau","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.actbio.2018.09.043_b0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1091\/mbc.e06-08-0674","article-title":"Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin","volume":"18","author":"Orian-Rousseau","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.actbio.2018.09.043_b0030","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/labinvest.2010.155","article-title":"De novo expression of CD44 variants in sporadic and hereditary gastric cancer","volume":"90","author":"da Cunha","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.actbio.2018.09.043_b0035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.stem.2014.01.009","article-title":"CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis","volume":"14","author":"Todaro","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.actbio.2018.09.043_b0040","doi-asserted-by":"crossref","first-page":"8811","DOI":"10.1007\/s13277-015-4755-6","article-title":"Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells","volume":"37","author":"Lv","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.actbio.2018.09.043_b0045","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1136\/gutjnl-2016-311447","article-title":"Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture","volume":"66","author":"Grillet","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.actbio.2018.09.043_b0050","first-page":"745","article-title":"CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer","volume":"22","author":"Okayama","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.actbio.2018.09.043_b0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jso.10082","article-title":"Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis","volume":"79","author":"Yamaguchi","year":"2002","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.actbio.2018.09.043_b0060","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3892\/or.2013.2273","article-title":"CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer","volume":"29","author":"Saito","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.actbio.2018.09.043_b0065","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.18632\/oncotarget.14163","article-title":"CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: a meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.actbio.2018.09.043_b0070","first-page":"4754","article-title":"Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression","volume":"53","author":"Wielenga","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2018.09.043_b0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00262-003-0494-4","article-title":"CD44v6: a target for antibody-based cancer therapy","volume":"53","author":"Heider","year":"2004","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.actbio.2018.09.043_b0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/19420862.2016.1269580","article-title":"Antibodies to watch in 2017","volume":"9","author":"Reichert","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.actbio.2018.09.043_b0085","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/07388551.2017.1357002","article-title":"Monoclonal antibodies: technologies for early discovery and engineering","volume":"38","author":"Kennedy","year":"2018","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.actbio.2018.09.043_b0090","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2018.09.043_b0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pharmthera.2017.03.004","article-title":"Antibodies and associates: partners in targeted drug delivery","volume":"177","author":"Kennedy","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.actbio.2018.09.043_b0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.addr.2011.04.006","article-title":"Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor","volume":"64","author":"Li","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2018.09.043_b0105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pmatsci.2017.05.001","article-title":"Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals","volume":"89","author":"Ara\u00fajo","year":"2017","journal-title":"Prog. Mater. Sci."},{"key":"10.1016\/j.actbio.2018.09.043_b0110","doi-asserted-by":"crossref","first-page":"14460","DOI":"10.1073\/pnas.1508522112","article-title":"Smart nanosystems: bio-inspired technologies that interact with the host environment","volume":"112","author":"Kwon","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.actbio.2018.09.043_b0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2018.09.043_b0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/btm2.10003","article-title":"Nanoparticles in the clinic","volume":"1","author":"Anselmo","year":"2016","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.actbio.2018.09.043_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/439389","article-title":"Antibody-conjugated nanoparticles for biomedical applications","volume":"2009","author":"Arruebo","year":"2009","journal-title":"J. Nanomater."},{"key":"10.1016\/j.actbio.2018.09.043_b0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/bab.1033","article-title":"Selection and in vitro characterization of human CD44v6-binding antibody fragments","volume":"59","author":"Nilvebrant","year":"2012","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.actbio.2018.09.043_b0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2191-219X-4-11","article-title":"In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study","volume":"4","author":"Haylock","year":"2014","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.actbio.2018.09.043_b0140","article-title":"CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling","author":"Lourenco","year":"2018","journal-title":"Integr. Biol."},{"key":"10.1016\/j.actbio.2018.09.043_b0145","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejpb.2018.03.005","article-title":"Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles","volume":"127","author":"Kennedy","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2018.09.043_b0150","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1038\/s41598-017-03959-4","article-title":"A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles","volume":"7","author":"Sousa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2018.09.043_b0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13346-017-0357-8","article-title":"Synthesis and characterization of chitosan-grafted-polycaprolactone micelles for modulate intestinal paclitaxel delivery","volume":"8","author":"Almeida","year":"2017","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.actbio.2018.09.043_b0160","first-page":"421","article-title":"N:NIH(S)-nu\/nu mice with combined immunodeficiency: a new model for human tumor heterotransplantation","volume":"65","author":"Azar","year":"1980","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.actbio.2018.09.043_b0165","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1021\/bm5010383","article-title":"Stability study perspective of the effect of freeze-drying using cryoprotectants on the structure of insulin loaded into PLGA nanoparticles","volume":"15","author":"Fonte","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2018.09.043_b0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jmb.2011.08.012","article-title":"HuCAL PLATINUM, a synthetic Fab library optimized for sequence diversity and superior performance in mammalian expression systems","volume":"413","author":"Prassler","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.actbio.2018.09.043_b0175","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1349-7006.1999.tb00773.x","article-title":"Silencing of the CD44 gene by CpG methylation in a human gastric carcinoma cell line","volume":"90","author":"Sato","year":"1999","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.actbio.2018.09.043_b0180","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2018.09.043_b0185","article-title":"Functionalizing PLGA and PLGA derivatives for drug delivery and tissue regeneration applications","author":"Martins","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2018.09.043_b0190","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2217\/nnm-2017-0023","article-title":"Delivery of siRNA silencing P-gp in peptide-functionalized nanoparticles causes efflux modulation at the blood-brain barrier","volume":"12","author":"Gomes","year":"2017","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.actbio.2018.09.043_b0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2018.09.043_b0200","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0927-7765(99)00156-3","article-title":"\u2018Stealth\u2019 corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption","volume":"18","author":"Gref","year":"2000","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.actbio.2018.09.043_b0205","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/cm402180t","article-title":"The Thiol-Michael addition click reaction: a powerful and widely used tool in materials chemistry","volume":"26","author":"Nair","year":"2014","journal-title":"Chem. Mater."},{"key":"10.1016\/j.actbio.2018.09.043_b0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.actbio.2018.09.043_b0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2008.09.086","article-title":"Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation","volume":"133","author":"Danhier","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2018.09.043_b0220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.anndiagpath.2015.10.010","article-title":"The expression of CD44v6 in colon: from normal to malignant","volume":"20","author":"Afify","year":"2016","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.actbio.2018.09.043_b0225","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0142-9612(96)86742-1","article-title":"Degradation of poly(d, l-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII)","volume":"17","author":"Landry","year":"1996","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2018.09.043_b0230","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.1021\/acsnano.5b02762","article-title":"Microfluidic assembly of a multifunctional tailorable composite system designed for site specific combined oral delivery of peptide drugs","volume":"9","author":"Ara\u00fajo","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2018.09.043_b0235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jconrel.2016.01.034","article-title":"Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery","volume":"225","author":"Fonte","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2018.09.043_b0240","first-page":"7371","article-title":"Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles","volume":"10","author":"Jahan","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2018.09.043_b0245","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/jps.22458","article-title":"Trehalose: current use and future applications","volume":"100","author":"Ohtake","year":"2011","journal-title":"J. Pharm. Sci."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706118305725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706118305725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:11:21Z","timestamp":1761671481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706118305725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":49,"alternative-id":["S1742706118305725"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2018.09.043","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2018.09.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}